The Samsung’s biopharmaceutical business is about to face KRW 1 trillion sales
The Samsung’s biopharmaceutical business, a new growth power of the company, is expected to enter a period of active growth.
The key of its biopharmaceutical business is classified into Samsung Biologics(manufacturing and distribution) and Samsung Bioepis(R&D).
Located in Songdo, the 1st factor...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
